'We Need to Change the Ecosystem', Habil Khorakiwala on India's Pharma Future | Rising Bharat
moneycontrol · 28 Oct 2026 · 19 min
Management interview of Wockhardt Ltd (WOCKPHARMA), with 1 key numbers discussed.
- Dr. Habil Khorakiwala, Founder and Chairman, Wockhardt
Wockhardt plans to launch its new antibiotic drug in India and the US within the next few months following FDA approval. Founder and Chairman Dr. Habil Khorakiwala noted that the company has half a dozen products planned over the next 10 years, while focusing its biologics and biosimilar portfolio on diabetes and obesity. He highlighted that growth from pure generic chemical entities is declining due to heightened competition. To establish India as an innovative pharma hub competing with China, he urged for science-based regulatory reforms and intellectual property framework improvements.